EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The cGAS/STING pathway in cancer: translating innate DNA sensing into therapeutic potential

Yi Wang, Juan Angulo-Lozano, Yueqi Wang, Liang Deng

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci204552 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Yi Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, USA. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Neoplasms, Membrane Proteins, Immunity, Innate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cGAS/STING pathway is a central innate immune DNA-sensing system that links aberrant DNA species to innate immune and stress-response transcriptional programs and has emerged as a key regulator of tumor-immune interactions. In cancer, pathway outputs are shaped by interconnected downstream signaling modules, including type I IFN, NF-κB, autophagy, and stress-metabolic checkpoints, as well as by stringent spatial and biochemical regulation of both cGAS and STING. When activation is acute and appropriately compartmentalized, cGAS/STING signaling promotes antitumor immunity across multiple cellular compartments in the tumor microenvironment, supporting DC cross-priming and cytotoxic lymphocyte responses. In contrast, chronic or dysregulated activation rewires downstream signaling toward stress-adaptive and inflammatory programs that promote tumor progression, metastasis, and immune dysfunction, including deleterious effects in lymphocytes and the induction of suppressive myeloid and B cell populations. Here, we examine how context determines the consequences of cGAS/STING activation in cancer, review emerging therapeutic strategies that modulate this pathway, and discuss how its antitumor potential can be maximized while minimizing systemic toxicity and immune dysregulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleotidyltransferasesNeoplasmsMembrane ProteinsImmunity, InnateSignal TransductionDNA, NeoplasmNeoplasm ProteinsHumansSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthasecGAS-STING Signaling PathwayAnimalsInnate Immunity RecognitionTumor Microenvironment

Substanzen

NucleotidyltransferasesSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseMembrane ProteinscGAS protein, humanSTING1 protein, humanDNA, NeoplasmNeoplasm Proteins

Autor:innen und Institutionen

  • Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, USA.
  • Department of Urology, Weill Cornell Medical College, New York, New York, USA.
  • Dermatology Service, Department of Medicine, and.
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Dermatology, Weill Cornell Medical College, New York, New York, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Wang, Y., Angulo-Lozano, J., Wang, Y., & Deng, L. (2026). The cGAS/STING pathway in cancer: translating innate DNA sensing into therapeutic potential. Journal of Clinical Investigation. https://doi.org/10.1172/jci204552

Vancouver

Wang Y, Angulo-Lozano J, Wang Y, Deng L. The cGAS/STING pathway in cancer: translating innate DNA sensing into therapeutic potential. Journal of Clinical Investigation. 2026. doi:10.1172/jci204552

BibTeX
@article{Wang2026,
  author = {Wang, Yi and Angulo-Lozano, Juan and Wang, Yueqi and Deng, Liang},
  title = {The cGAS/STING pathway in cancer: translating innate DNA sensing into therapeutic potential},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci204552}
}
Kostenlos starten →